Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)A study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease
PolandA study testing tulisokibart for people with rheumatoid arthritis who have not responded well enough to previous treatments
PolandA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
PolandA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
PolandStudy of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years
PolandStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
PolandStudy of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years
PolandStudy of tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)
PolandStudy of LY3457263 compared to placebo in adults with type 2 diabetes who are taking semaglutide or tirzepatide but have not reached their blood sugar goals
PolandComparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control
PolandStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
PolandStudy of cagrilintide for weight reduction in adults with overweight or obesity when combined with lifestyle changes
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
